117 related articles for article (PubMed ID: 30959177)
41. Localization of brachytherapy seeds in MRI by deconvolution.
Dong Y; Chang Z; Whitehead G; Ji J
Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():2960-3. PubMed ID: 24110348
[TBL] [Abstract][Full Text] [Related]
42. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the visibility of a new thinner ¹²⁵I radioactive source for permanent prostate brachytherapy.
Roberts G; Al-Qaisieh B; Bownes P
Brachytherapy; 2012; 11(6):460-7. PubMed ID: 22436518
[TBL] [Abstract][Full Text] [Related]
44. Seed localization in ultrasound and registration to C-arm fluoroscopy using matched needle tracks for prostate brachytherapy.
Moradi M; Mahdavi SS; Dehghan E; Lobo JR; Deshmukh S; Morris WJ; Fichtinger G; Salcudean ST
IEEE Trans Biomed Eng; 2012 Sep; 59(9):2558-67. PubMed ID: 22759435
[TBL] [Abstract][Full Text] [Related]
45. Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study.
Jelvehgaran P; Alderliesten T; Weda JJA; de Bruin M; Faber DJ; Hulshof MCCM; van Leeuwen TG; van Herk M; de Boer JF
Med Phys; 2017 Dec; 44(12):6570-6582. PubMed ID: 29023771
[TBL] [Abstract][Full Text] [Related]
46. Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom.
Schneider S; Jølck RI; Troost EGC; Hoffmann AL
Med Phys; 2018 Jan; 45(1):37-47. PubMed ID: 29136287
[TBL] [Abstract][Full Text] [Related]
47. Three-dimensional seed reconstruction from an incomplete data set for prostate brachytherapy.
Narayanan S; Cho PS; Marks RJ
Phys Med Biol; 2004 Aug; 49(15):3483-94. PubMed ID: 15379027
[TBL] [Abstract][Full Text] [Related]
48. Comparison of template-matching and singular-spectrum-analysis methods for imaging implanted brachytherapy seeds.
Alam SK; Mamou J; Feleppa EJ; Kalisz A; Ramachandran S
IEEE Trans Ultrason Ferroelectr Freq Control; 2011 Nov; 58(11):2484-91. PubMed ID: 22083781
[TBL] [Abstract][Full Text] [Related]
49. Multi-echo gradient recalled echo imaging of the pelvis for improved depiction of brachytherapy seeds and fiducial markers facilitating radiotherapy planning and treatment of prostatic carcinoma.
Schieda N; Avruch L; Shabana WM; Malone SC
J Magn Reson Imaging; 2015 Mar; 41(3):715-20. PubMed ID: 24510444
[TBL] [Abstract][Full Text] [Related]
50. BrachyView: Combining LDR seed positions with transrectal ultrasound imaging in a prostate gel phantom.
Alnaghy S; Cutajar DL; Bucci JA; Enari K; Safavi-Naeini M; Favoino M; Tartaglia M; Carriero F; Jakubek J; Pospisil S; Lerch M; Rosenfeld AB; Petasecca M
Phys Med; 2017 Feb; 34():55-64. PubMed ID: 28118951
[TBL] [Abstract][Full Text] [Related]
51. Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy.
French D; Morris J; Keyes M; Goksel O; Salcudean S
Acad Radiol; 2005 Oct; 12(10):1262-72. PubMed ID: 16179203
[TBL] [Abstract][Full Text] [Related]
52. In vitro comparative study of vibro-acoustography versus pulse-echo ultrasound in imaging permanent prostate brachytherapy seeds.
Mitri FG; Davis BJ; Greenleaf JF; Fatemi M
Ultrasonics; 2009 Jan; 49(1):31-8. PubMed ID: 18538365
[TBL] [Abstract][Full Text] [Related]
53. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
Abboud F; Scalliet P; Vynckier S
Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
[TBL] [Abstract][Full Text] [Related]
54. Fiducial markers in prostate for kV imaging: quantification of visibility and optimization of imaging conditions.
Chen Y; O'Connell JJ; Ko CJ; Mayer RR; Belard A; McDonough JE
Phys Med Biol; 2012 Jan; 57(1):155-72. PubMed ID: 22127351
[TBL] [Abstract][Full Text] [Related]
55. Measurement of the ultrasound backscatter signal from three seed types as a function of incidence angle: application to permanent prostate brachytherapy.
Davis BJ; Kinnick RR; Fatemi M; Lief EP; Robb RA; Greenleaf JF
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1174-82. PubMed ID: 14575850
[TBL] [Abstract][Full Text] [Related]
56. Prostate brachytherapy seed localization with Gaussian blurring and camera self-calibration.
Lee J; Liu X; Prince JL; Fichtinger G
Med Image Comput Comput Assist Interv; 2008; 11(Pt 2):636-43. PubMed ID: 18982658
[TBL] [Abstract][Full Text] [Related]
57. BrachyView: proof-of-principle of a novel in-body gamma camera for low dose-rate prostate brachytherapy.
Petasecca M; Loo KJ; Safavi-Naeini M; Han Z; Metcalfe PE; Meikle S; Pospisil S; Jakubek J; Bucci JA; Zaider M; Lerch ML; Qi Y; Rosenfeld AB
Med Phys; 2013 Apr; 40(4):041709. PubMed ID: 23556879
[TBL] [Abstract][Full Text] [Related]
58. Detection of brachytherapy seeds using 3-D transrectal ultrasound.
Wen X; Salcudean ST; Lawrence PD
IEEE Trans Biomed Eng; 2010 Oct; 57(10):2467-77. PubMed ID: 20595088
[TBL] [Abstract][Full Text] [Related]
59. The detectability and localization accuracy of implanted fiducial markers determined on in-room computerized tomography (CT) and electronic portal images (EPI).
Owen R; Kron T; Foroudi F; Cox J; Zhu L; Cramb J; Sparks L; Duchesne G
Med Dosim; 2008; 33(3):226-33. PubMed ID: 18674688
[TBL] [Abstract][Full Text] [Related]
60. High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors.
Hong JC; Yu Y; Rao AK; Dieterich S; Maxim PG; Le QT; Diehn M; Sze DY; Kothary N; Loo BW
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):85-90. PubMed ID: 20675070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
